<!DOCTYPE html>
<html  lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  <head>
    <meta charset="utf-8" />
<script async src="https://www.googletagmanager.com/gtag/js?id=G-273DTKB5QW"></script>
<meta name="description" content="CGMP/QSR/Medical Devices/Adulterated" />
<meta name="dcterms.title" content="Unimicro Medical Systems-Shenzhen Co., Ltd. - 624560 - 01/06/2022" />
<meta name="dcterms.creator" content="Center for Devices and Radiological Health" />
<meta name="dcterms.description" content="CGMP/QSR/Medical Devices/Adulterated" />
<meta name="dcterms.publisher" content="FDA" />
<meta name="dcterms.source" content="FDA" />
<meta property="og:site_name" content="U.S. Food and Drug Administration" />
<meta property="og:type" content="Article" />
<meta property="og:url" content="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/unimicro-medical-systems-shenzhen-co-ltd-624560-01062022" />
<meta property="og:title" content="Unimicro Medical Systems-Shenzhen Co., Ltd. - 624560 - 01/06/2022" />
<meta property="og:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" />
<meta property="og:updated_time" content="Tue, 03/22/2022 - 09:20" />
<meta property="og:street_address" content="201, Bldg 38 101 Heshui Kou" />
<meta property="og:locality" content="Shenzhen" />
<meta property="og:postal_code" content="518106" />
<meta property="og:country_name" content="CN" />
<meta property="article:publisher" content="FDA" />
<meta property="article:published_time" content="Wed, 03/19/2025 - 15:14" />
<meta property="article:modified_time" content="Tue, 03/22/2022 - 09:20" />
<meta name="google-site-verification" content="tWxlDhm4ANdksJZPj7TBmHgNoMqZCnecPp0Aa2vC9XA" />
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:site" content="@US_FDA" />
<meta name="twitter:title" content="Unimicro Medical Systems-Shenzhen Co., Ltd. - 624560 - 01/06/2022" />
<meta name="twitter:creator" content="@US_FDA" />
<meta name="twitter:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<script type="application/ld+json">{
    "@context": "https://schema.org",
    "@graph": [
        {
            "@type": "Article",
            "headline": "Unimicro Medical Systems-Shenzhen Co., Ltd. - 624560 - 01/06/2022",
            "name": "Unimicro Medical Systems-Shenzhen Co., Ltd. - 624560 - 01/06/2022",
            "description": "CGMP/QSR/Medical Devices/Adulterated",
            "image": {
                "@type": "ImageObject",
                "representativeOfPage": "True",
                "url": "/themes/custom/preview/img/FDA-Social-Graphic.png"
            },
            "datePublished": "Wed, 03/19/2025 - 15:14",
            "dateModified": "Tue, 03/22/2022 - 09:20",
            "author": {
                "@type": "Organization",
                "name": "Center for Devices and Radiological Health"
            },
            "publisher": {
                "@type": "Organization",
                "name": "FDA"
            }
        }
    ]
}</script>
<meta property="og:description" content="CGMP/QSR/Medical Devices/Adulterated" />
<meta property="twitter:description" content="CGMP/QSR/Medical Devices/Adulterated" />
<link rel="icon" href="/themes/custom/preview/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="alternate" hreflang="en" href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/unimicro-medical-systems-shenzhen-co-ltd-624560-01062022" />
<link rel="canonical" href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/unimicro-medical-systems-shenzhen-co-ltd-624560-01062022" />
<link rel="shortlink" href="https://www.fda.gov/node/413071" />
<script src="/files/google_tag/production/google_tag.script.js?t5y79a" defer></script>

    <title>Unimicro Medical Systems-Shenzhen Co., Ltd. - 624560 - 01/06/2022 | FDA</title>
    <link rel="stylesheet" media="all" href="/files/css/css_I1lI2DYRy4WvhS49GZC8Z2v9NUFD60djX72-ZNQ0RPY.css?delta=0&amp;language=en&amp;theme=preview&amp;include=eJxNzEsOwjAMRdENBbykKJ9HZeLGJXZA2T2CQWFydUa3NFR2HZF7RfcsWhr9Odgyx045GcIx8GS8aBPNSS7mS7hv4f6YGCtOjjU5Di4Ng34MN1Xv6jA6FT4fo2-vu9YpeAPskjb1" />
<link rel="stylesheet" media="all" href="/files/css/css_hj_HG-FreAYyrzLosS3-54RaarbPLxzHFgHCJpFJLhA.css?delta=1&amp;language=en&amp;theme=preview&amp;include=eJxNzEsOwjAMRdENBbykKJ9HZeLGJXZA2T2CQWFydUa3NFR2HZF7RfcsWhr9Odgyx045GcIx8GS8aBPNSS7mS7hv4f6YGCtOjjU5Di4Ng34MN1Xv6jA6FT4fo2-vu9YpeAPskjb1" />

    <script src="https://script.crazyegg.com/pages/scripts/0024/3700.js" async></script>
<script src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&amp;subagency=FDA&amp;sdor=fda.gov&amp;dclink=true" language="javascript" id="_fed_an_ua_tag"></script>

            <script>window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag("js", new Date());gtag("set", "developer_id.dMDhkMT", true);gtag("config", "G-273DTKB5QW", {"groups":"default","page_placeholder":"PLACEHOLDER_page_location","allow_ad_personalization_signals":false});</script>
        
  </head>
  <body class="role-anonymous path-node page-node-type-warning-letter has-glyphicons">
      <div id="quicklinks" class="sr-only display-on-focus">
        <ul class="list-inline padding-left-3 padding-right-3">
          <li><a href="#main-content" class="btn btn-default margin-top-3" tabindex="1">Skip to main content</a></li>
          <li><a href="#search-form" class="btn btn-default margin-top-3" tabindex="1">Skip to FDA Search</a></li>
          <li><a href="#section-nav" class="btn btn-default margin-top-3" tabindex="1">Skip to in this section menu</a></li>
          <li><a href="#footer" class="btn btn-default margin-top-3" tabindex="1">Skip to footer links</a></li>
        </ul>   
      </div>    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M95XGZW" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
       
  <div class="main-container container-fluid">     <div class="row">
                                                               


	
	<header class="lcds-header container-fluid" role="banner">
		                    
			<div class="row us-masthead">                            

				<div class="usa-banner col-xs-12">

					<img class="usa-banner__us-flag" src="/themes/custom/preview/assets/images/US_Flag.png" alt="U.S. flag" />

					<span>An official website of the United States government</span>

				    <a id="USMenuButton" class="collapsed" role="button" aria-expanded="false" aria-controls="USABannerMenu" href="#" data-toggle="collapse" data-target="#USABannerMenu">Here’s how you know <span class="toggle-indicator"> </span></a>

          			<div class="col-xs-12 collapse usa-banner__menu" id="USABannerMenu" aria-labelledby="USMenuButton">


						<div id="gov-banner" class="row usa-banner-content usa-grid usa-accordion-content" aria-hidden="true">
							      <div class="col-xs-12 col-sm-6 col-md-3">
							        <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-dot-gov.svg" alt="Dot gov" style="width:3em;">
									<div class="usa-media_block-body">
								      <p><strong>The .gov means it’s official.</strong><br>Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.</p>
								    </div>
							      </div>
							      <div class="col-xs-12 col-sm-6 col-md-3">
							        <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-https.svg" alt="SSL" style="width:3em;">
							        <div class="usa-media_block-body">
								         <p><strong>The site is secure.</strong><br> The <strong>https://</strong> ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.</p>
							        </div>
							      </div>
						</div>
					</div>

				</div>
			</div> 			<div class="row fda-masthead">
							<div class="col-xs-4 col-md-8 fda-masthead__fda-logo"> 
					<a href="/" title="FDA Homepage">
            <picture>
              <!-- Set media breakpoint to value equivalent to $screen-md -->
              <source media="(min-width:992px)" srcset="/themes/custom/preview/assets/images/gov-fda-new-white.svg">
              <img src="/themes/custom/preview/assets/images/FDA_Logo_Icon_White.svg" height="40px" alt="U.S. Food and Drug Administration logo">
            </picture>
          </a>
       	</div>
				
        <div class="col-xs-8 col-md-4">
        <ul class="fda-masthead__item-list">
            <li>
                <button id="btn-search" class="btn btn-default btn-sm fda-masthead__btn-search" aria-expanded="false" aria-controls="search-form" title="Open search bar">
					<span class="fa fa-search" aria-hidden="true">&nbsp;</span>
			    	<span class="fda-masthead__btn-label">Search</span>
				</button>
            </li>
            <li>
                <button id="menu-btn" class="btn btn-default btn-sm fda-masthead__btn-menu collapsed" href="#primary-nav" data-toggle="collapse" aria-expanded="true">
                    <span class="fa fa-bars" aria-hidden="true">&nbsp;</span>
                    <span class="fda-masthead__btn-label">Menu</span>
                </button>
            </li>
        </ul>
		</div>
							
						<form class="fda-masthead__search sr-only" id="search-form" aria-hidden="true" role="search" action="/search" method="GET" accept-charset="UTF-8">
							<div class="search-popover" id="search-popover">
								<div class="input-group pull-right" id="search-group">
									<label class="sr-only" for="search-query">Search FDA</label>
									
									<input class="form-control search-input" tabindex="-1" id="search-query" name="s" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA"  type="text" /> 
									
									<span class="input-group-btn" id="input-group-btn">
										
										<button type="submit" type="button" class="btn btn-danger search-btn" id="search-btn" tabindex="-1" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button>

									</span>

								</div>
							</div>
																				
						</form>					

			</div> 
		<nav id="primary-nav" class="lcds-primary-nav row collapse">					<div class="col-md-5 col-lg-4">
						<section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
							<h2 class="lcds-primary-nav__group-heading">Featured</h2>
							<ul class="lcds-primary-nav__list lcds-primary-nav__list--featured">
								<li class="lcds-primary-nav__list-item"><a href="https://www.safetyreporting.hhs.gov/smarthub#/" title="Report a Problem with an FDA Regulated Product">Report a Product Problem</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/about-fda/contact-fda">Contact FDA</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/regulatory-information/search-fda-guidance-documents">FDA Guidance Documents</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/safety/recalls-market-withdrawals-safety-alerts">Recalls, Market Withdrawals and Safety Alerts</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/news-events/newsroom/press-announcements">Press Announcements</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters">Warning Letters</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/advisory-committees">Advisory Committees</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/fda-en-espanol">En Espa&#241ol</a></li>
							</ul>
						</section>
					</div>

					<div class="col-md-7 col-lg-8">
          <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
            <h2 class="lcds-primary-nav__group-heading">Products</h2>
            <ul class="lcds-primary-nav__list">
							<li class="lcds-primary-nav__list-item"><a href="/food">Food</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/drugs">Drugs</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/medical-devices">Medical Devices</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/radiation-emitting-products">Radiation-Emitting Products</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/vaccines-blood-biologics">Vaccines, Blood, and Biologics</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/animal-veterinary">Animal and Veterinary</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/cosmetics">Cosmetics</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/tobacco-products">Tobacco Products</a></li>
            </ul>
          </section>
          <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
            <h2 class="lcds-primary-nav__group-heading">Topics</h2>
            <ul class="lcds-primary-nav__list">
							<li class="lcds-primary-nav__list-item"><a href="/about-fda">About FDA</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/combination-products">Combination Products</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/regulatory-information">Regulatory Information</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/safety">Safety</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/emergency-preparedness-and-response">Emergency Preparedness</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/international-programs">International Programs</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/news-events">News and Events</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/training-and-continuing-education">Training and Continuing Education</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations">Inspections and Compliance</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/science-research">Science and Research</a></li>
            </ul>
          </section>
          <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
            <h2 class="lcds-primary-nav__group-heading">Information For</h2>
            <ul class="lcds-primary-nav__list">
	            <li class="lcds-primary-nav__list-item"><a href="/consumers">Consumers</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/patients">Patients</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/industry">Industry</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/health-professionals">Health Professionals</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/federal-state-local-tribal-and-territorial-officials">Federal, State and Local Officials</a></li>
            </ul>
          </section>
					</div>
	      </nav>
    </header>

<div class="col-xs-12">
	<div data-drupal-messages-fallback class="hidden"></div>

</div>

                              
                                                                     <section id="block-entityviewcontent" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      

<a class="lcds-button--expandable collapsed hidden-md hidden-lg" data-toggle="collapse" href="#section-nav" >In this section<span class="visible-sm-inline-block">:

                Warning Letters
    
    </span>
</a>

<nav id="section-nav" class="lcds-card lcds-section-nav lcds-section-nav hidden-md hidden-lg collapse">

    <ul class="lcds-section-nav__list">

      <li>

              <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters" title="Warning Letters" class="lcds-section-nav__section-link lcds-section-nav__link lcds-section-nav__parent-link visible-xs-block visible-sm-block">
                                        Warning Letters
                    </a>

                        <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_5 js-view-dom-id-7e5c6e01e1d5dc32b468fa0a307e5be8182adf5d2b89688d3e404a359eebe0f3">
  
    
      
  
      <div>
  
  <ul class="lcds-section-nav__section-link__active lcds-section-nav__list">

          <li><a href="/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/about-warning-and-close-out-letters" class="lcds-section-nav__link">About Warning and Close-Out Letters</a></li>
    
  </ul>

</div>


  
          </div>
</div>


                        <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_2 js-view-dom-id-67b606635e14255d392c8c9691dc3a9f8b3366a42703aa54bb7ecc1a8d9d0851">
  
    
      
  
          </div>
</div>


      </li>

    </ul>

</nav>

  </section>

<section id="block-entityviewcontent-15" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      
    <ol class="lcds-breadcrumb visible-md visible-lg">
          <li >
                  <a href="/">Home</a>
              </li>
          <li >
                  <a href="/inspections-compliance-enforcement-and-criminal-investigations">Inspections, Compliance, Enforcement, and Criminal Investigations</a>
              </li>
          <li >
                  <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities">Compliance Actions and Activities</a>
              </li>
          <li >
                  <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters">Warning Letters</a>
              </li>
          <li >
                  <a class="current-link">Unimicro Medical Systems-Shenzhen Co., Ltd. - 624560 - 01/06/2022</a>
              </li>
      </ol>




<ol class="lcds-breadcrumb visible-sm visible-xs">
  <li>
    <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters" title="Warning Letters">
     Warning Letters
    </a>
  </li>
</ol>

  </section>






                                
      <main>

                                 <article id="main-content" class="article main-content container-fluid" role="article">
          
                                                                <header class="row content-header">
                         <section id="block-entityviewcontent-8" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      
<div class="col-sm-12 col-md-8 col-md-offset-2">

        <p class="content-type-label text-center">WARNING LETTER</p>
      <h1 class="text-center content-title">Unimicro Medical Systems-Shenzhen Co., Ltd.
            
      <span class="font-family-sans">
                  MARCS-CMS 624560 —           <time datetime="2022-01-06T00:00:00Z">January 06, 2022</time>
</span></h1>


    
 
</div>

  </section>






                      </header>
                              
                                                          
                              <aside class="col-md-2" role="complementary">
                  <section id="block-entityviewcontent-3" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

        <div class="region region-">
    <p class="text-center "><a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters" class="btn btn-default"><i class="fa fa-arrow-circle-left" aria-hidden="true"></i> More Warning Letters</a></p>

     
    <nav id="section-nav"class="lcds-card lcds-section-nav lcds-section-nav--side hidden-xs hidden-sm">
      <ul class="lcds-section-nav__list lcds-section-nav--side__list">
        <li>

                    <a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters" title="Warning Letters" class="lcds-section-nav__link lcds-section-nav--side__link lcds-section-nav__parent-link lcds-section-nav--side__parent-link">
                                        Warning Letters
                      </a>

          
                        <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_4 js-view-dom-id-5a5a126cf5152446f661d0e73024b545b10f4c1c2df9cd0ed781b07f8c99a296">
  
    
      
  
      <div class="item-list">
  
  <ul class="lcds-section-nav__active lcds-section-nav__list lcds-section-nav--side__list">

          <li><a href="/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/about-warning-and-close-out-letters" class="lcds-section-nav__link lcds-section-nav--side__link">About Warning and Close-Out Letters</a></li>
    
  </ul>

</div>


  
          </div>
</div>


        </li>
      </ul> 
    </nav>
  </div>    

  </section>


                </aside>
              
                                                          
              <div class="col-md-8" role="main">

                            
                            
                            
                            
                                              
  
 

                 

  <hr>
 

<div class="inset-column">
  <dl class="lcds-description-list--grid">

              <dt class="cell-1_1">Delivery Method:</dt> 
        <dd class="cell-2_1">VIA UNITED PARCEL SERVICE
                                                                                                                                                                                                                                                                                                                                                                                                                              </dd>
      
      
              <dt class="cell-1_3">Product:</dt> 
        <dd class="cell-2_3">Medical Devices                          
            
            
            
            
            
            
            
             
            
            
            
              
            
            
            </dd>
      
          </dl>
  </div>            


<hr>

<div class="row inset-column">
  <div class="col-xs-12 col-md-6">
    <dl class="">

        <dt>Recipient:</dt>

                      <dd>
  <div class="field field--name-field-recipient-name field--type-string field--label-above">
    <div class="field--label">Recipient Name</div>
              <div class="field--item">Roly Lee</div>
          </div>
</dd>
                                <dd>
  <div class="field field--name-field-recipient-title field--type-string field--label-above">
    <div class="field--label">Recipient Title</div>
              <div class="field--item">General Manager</div>
          </div>
</dd>
          
            <dd>Unimicro Medical Systems-Shenzhen Co., Ltd.</dd>

          
                      <dd><p class="address" translate="no"><span class="address-line1">201, Bldg 38 101 Heshui Kou</span><br>
<span class="dependent-locality">Gongmingzhen Longgang</span><br>
<span class="locality">Shenzhen</span><br>
<span class="postal-code">518106</span><br>
<span class="country">China</span></p></dd>
          
          
          
    </dl>
  </div>            

       <div class="col-xs-12 col-md-6">
    <dl class="">
          
          <dt>Issuing Office:</dt>
        
         
          <dd>Center for Devices and Radiological Health</dd>
        
         
          <dd><p class="address" translate="no"><span class="country">United States</span></p></dd>
        
        
        
        
        
    </dl>
    <dl class=""> 
      
    </dl>
  </div>  
      
</div>

 

 

<hr>

<p class="text-align-center"><strong>WARNING LETTER</strong></p>

<p>January 6, 2022</p>

<p>Dear Roly Lee:</p>

<p>During an inspection of your firm located in Shenzhen, China, on September 15, 2021, through September 26, 2021, an investigator from the United States Food and Drug Administration (FDA) determined that your firm manufactures Veress Pneumoperitoneum Needles. Under section 201(h) of the Federal Food, Drug, and Cosmetic Act (the Act), 21 U.S.C. § 321(h), these products are devices because they are intended for use in the diagnosis of disease or other conditions or in the cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the body.</p>

<p>This inspection revealed that these devices are adulterated within the meaning of section 501(h) of the Act, 21 U.S.C. § 351(h), in that the methods used in, or the facilities or controls used for, their manufacture, packing, storage, or installation are not in conformity with the current good manufacturing practice requirements of the Quality System regulation found at Title 21, Code of Federal Regulations (CFR), Part 820. These violations include, but are not limited to, the following:</p>

<p>1. Failure to adequately establish and maintain procedures to control product that does not conform to specified requirements as required by 21 CFR 820.90(a).</p>

<p>For example: Your firm has not established a disposition process for product that does not conform to specified requirements. Your firm was not able to provide the disposition of <strong>(b)(4)</strong> package heat sealed nonconforming products. In Nonconforming Product Handling Sheet (No. <strong>(b)(4)</strong>, dated <strong>(b)(4)</strong>), your firm noted <strong>(b)(4)</strong> package heat sealing nonconformances. For these <strong>(b)(4)</strong> nonconforming products, the final determination was stated as “return to warehouse” and no final disposition was provided or conducted, per Nonconforming Product Control Procedure (Doc No. <strong>(b)(4)</strong>, Ver. <strong>(b)(4)</strong>, and dated <strong>(b)(4)</strong>). Therefore, it is unknown where these products are or how they were handled. Additionally, your firm’s staff was unaware of the nonconforming product procedure or handling and disposition of nonconforming products.</p>

<p>We have reviewed your firm’s response in the 483 Corrective Action Plan dated October 8, 2021 and have concluded it is not adequate. You plan to stop any products exporting to the United States of America until corrective actions are completed and deactivate all products from your Device Listings until the corrective actions are completed. You also plan to modify the Nonconforming Product Control Procedure, train relevant personnel of the design, purchasing, quality, production, warehouse, logistics, and sales department according to the revised procedure. You state you will also perform retrospective review for all products which have been sold for the US market, to analyze if there is any quality issue or adverse events that have occurred. However, to ensure a sufficient evaluation of the risk posed by the situation, you should also actively evaluate the risks associated with the device presently and take any needed actions to mitigate those risks. This should not rely only on adverse event reporting or other outside reporting. Additionally, your Corrective Action Plan does not include ensuring the disposition of nonconforming products are documented. As part of your corrective actions, you should document the disposition of the identified nonconforming products.</p>

<p>2. Failure to adequately establish and maintain procedures to control the design of the device in order to ensure that specified design requirements are met as required by 21 CFR 820.30(a).</p>

<p>For example: Your firm was unable to provide documentation and/or evidence of conducting Design and Development activities as described in the Design and Development Control Procedures (Doc No. <strong>(b)(4)</strong>, Ver. <strong>(b)(4)</strong>, dated <strong>(b)(4)</strong>), related to the veress pneumoperitoneum needles. In this document, the procedures for design control are described in detail. The procedures include steps to review the design input, output, verification and validation, design changes, design transfer, and design history. However, your firm was unable to provide documentation and data demonstrating design requirements for the veress pneumoperitoneum needles wet met, as required by the Design and Development Control Procedures.</p>

<p>We have reviewed your firm’s response in the 483 Corrective Action Plan dated October 8, 2021 and have concluded it is not adequate. You plan to modify the Design and Development Control Procedure based on the requirements of 21 CFR 820.30 Design Control, train all design personnel according to the revised procedure, and to retrospectively review all products which have been sold for the U.S market, to analyze if there is any quality issue or adverse events occurred. However, you have no plan to evaluate the retrospectively conduct design control activities for affected products. You should conduct a review of your products to determine which products did not have design control activities conducted and retrospectively conduct those activities to ensure products meet design requirements. In addition, you should actively assess if lack of design control activities could have led to the distribution of nonconforming products (aside from review of adverse event or malfunction reports). If any risks are identified, you should take appropriate action to mitigate those risks.</p>

<p>3. Failure to adequately establish and maintain procedures for monitoring and control of process parameters for validated processes to ensure that the specified requirements continue to be met, as required by 21 CFR 820.75(b).</p>

<p>For example: Your firm was unable to provide validation documentation with objective evidence and data for activities related to the manufacturing of medical devices, specifically EtO Sterilization, Heat Sealing Packaging, and UV Glue Curing documented in the Validation Management Control Procedure (Doc No. <strong>(b)(4)</strong>, Ver. No. <strong>(b)(4)</strong> and dated <strong>(b)(4)</strong>), Sealing Machine Sealing Effect Re-Verification Program (Doc No. <strong>(b)(4)</strong>, Ver. <strong>(b)(4)</strong> and dated <strong>(b)(4)</strong>), Sealing Machine Sealing Effect Re-Verification Report (Doc No. <strong>(b)(4)</strong>, Ver. <strong>(b)(4)</strong> and dated <strong>(b)(4)</strong>), UV Curing Re-Verification Program (Doc No. <strong>(b)(4)</strong>, Ver. <strong>(b)(4)</strong> and dated <strong>(b)(4)</strong>). Your firm also did not have personnel familiar with process validation.</p>

<p>We have reviewed your firm’s response in the 483 Corrective Action Plan dated October 8, 2021 and have concluded it is not adequate. You plan to modify the validation management control procedure based on the requirement of 21 CFR 820.75 Process validation, train all validation personnel according to the revised procedure, re-validate all other special processes identified for U.S products such as the ultrasonic cleaning process and ultrasonic welding process, and re-validate the EtO sterilization process, heat sealing packaging process, and UV glue curing process. However, these activities have not been completed. In addition, you have not indicated if or how you plan to assess any potential impacts of the lack of process validation on previously distributed product and how you plan to mitigate any associated risks. To ensure safety and conformity of product, it is important that you assess the potential impact the lack of process validation as described above, may have had on previously distributed products as part of your corrective action plan.</p>

<p>4. Failure to adequately establish and maintain procedures for implementing corrective and preventive action as required by 21 CFR 820.100(a).</p>

<p>For example: Your firm did not provide a severity determination, or a root cause analysis conducted for CAPA events deemed “necessary”. The CAPA states a root cause analysis is required to be conducted only if necessary. However, your firm has not defined what CAPA events are necessary in the Corrective and Preventive Actions Control Procedure (Doc No. <strong>(b)(4)</strong> Ver. <strong>(b)(4)</strong> dated <strong>(b)(4)</strong>). In the document, your firm utilizes an in-process CAPA, which requires a severity determination, which is not defined in the procedure. There is no documented definition, requirement, or guidance in the procedure for the severity determination. Also, no root cause analysis was performed in your firm’s two most recent CAPAs, (Abnormal Manufacturing Process Feedback Memo <strong>(b)(4)</strong> for Model MND11500 and Model MND11200).</p>

<p>We have reviewed your firm’s response in the 483 Corrective Action Plan. The adequacy of the response dated October 8, 2021, cannot be determined at this time. You plan to modify the Corrective and Preventive Action Control Procedure to define severity (Major, Moderate, or Minor), and define what is “necessary” when requiring a root cause analysis. You intend to train relevant personnel of all departments according to the revised procedure. You also state you will investigate the past CAPAs and customer complaints, to confirm whether there is any improper handling of CAPAs or customer complaints, and to evaluate the risks to the products that have been sold in the US market. These actions have not been completed; therefore, the adequacy of these actions cannot be determined until the activities described have been completed and documentation verifying the successful completion of these actions are provided.</p>

<p>5. Failure to adequately establish and maintain procedures to ensure that equipment is routinely calibrated, inspected, checked, and maintained as required by 21 CFR 820.72(a).</p>

<p>For example: Your firm was not able to provide calibration documentation and data related to equipment and instruments including leakage tester and push &amp; pull tester, used in the manufacturing of medical devices intended for the US market. Your firm was able to provide the calibration procedure, Production Equipment Management Control Procedure (Doc No. <strong>(b)(4)</strong>, Ver. <strong>(b)(4)</strong>, and dated <strong>(b)(4)</strong>). However, when calibration documentation for equipment and instruments used during the manufacturing of the Class II Veress Needles, such as their Leakage Tester and Push &amp; Pull Tester, your firm was unable to provide calibration documentation and data.</p>

<p>We have reviewed your firm’s response in the 483 Corrective Action Plan. The adequacy of the response dated October 8, 2021, cannot be determined at this time. You plan to modify the production equipment management control procedure based on the requirements of 21 CFR 820.72(a) and train relevant personnel of quality, production, and warehouse departments according to the revised procedure. You also plan to send Leakage Tester and Push&amp;Pull Tester to the Calibration institute for calibration. Additionally, you state that you will review the impact of their Leakage Tester and Push&amp;Pull Tester on the product test results during the failure period based on the calibration results. Lastly, you plan to review the measuring and test equipment for any of the same issues for other inspection, measuring, and test equipment. These actions have not been completed; therefore, the adequacy of these actions cannot be determined until the activities described have been completed, and documentation verifying the successful completion of these actions are provided.</p>

<p>6. Failure to adequately establish and maintain acceptance procedures, where appropriate, to ensure that specified requirements for in-process product are met as required by 21 CFR 820.80(c).</p>

<p>For example: Your firm’s Veress Needle Quality Inspection Standard (Doc No. <strong>(b)(4)</strong>, Ver. <strong>(b)(4)</strong>, dated <strong>(b)(4)</strong>) is not adequately established, as the quality control personnel were conducting in-process acceptance activities that did not include connection bond testing, and puncture testing of the subject device. Your firm has not established and maintained in-process acceptance activity procedures to ensure specified requirements for in-process products are met. The quality personnel were conducting acceptance activities based on the Inspection Standard used to conduct in-process acceptance activities for the Veress Needles. However, according to the investigator, your firm’s quality staff conducting the in-process acceptance activities were not familiar with the testing process and stated there were no established in-process acceptance procedures for the connection bond and puncture testing. However, in the Semi-Finished Inspection Record (<strong>(b)(4)</strong>), there is a requirement included to conduct a connection bond test and puncture test, that the quality staff conducting the in-process acceptance activities were not familiar with. The requirement listed in the semi-finished inspection record was not included in the final Veress Needle Quality Inspection Standard.</p>

<p>We have reviewed your firm’s response in the 483 Corrective Action Plan dated October 8, 2021, and have concluded it is not adequate. You plan to modify the Veress Needle Quality Inspection Standard and all other quality inspection standards, train relevant personnel of the quality and production department according to the revised Quality Inspection Standards, and perform retrospective review for all products which had been sold for the U.S market, to analyze if there is any quality issue or adverse event occurred. These actions have not been completed. In addition, your firm has not identified plans to evaluate their document control system, to make changes to ensure the requirements are consistent across documents. To ensure conformance to the standard across all relevant in-process acceptance activities, you should evaluate your document control system as part of your corrective action plan.</p>

<p>7. Failure to adequately establish and maintain procedures to ensure that DHR's for each batch, lot, or unit are maintained to demonstrate that the device is manufactured in accordance with the DMR, and the requirements of this part as required by 21 CFR 820.184</p>

<p>For example: Your firm was not able to provide Device History Records for their manufactured medical devices intended and exported to the US market. Your firm was unfamiliar with FDA regulations and requirements for manufactures to include the DHR requirements and their Device History Record Control Procedures (Doc No. <strong>(b)(4)</strong>, Ver. <strong>(b)(4)</strong> and dated <strong>(b)(4)</strong>).</p>

<p>We have reviewed your firm’s response in the 483 Corrective Action Plan. The adequacy of the response dated October 8, 2021, cannot be determined at this time. You state you intend to modify their DHR control procedures based on the requirements of 21 CFR 820.184 and perform sample inspection of <strong>(b)(4)</strong> batches of the subject device based on the revised procedure, to confirm the integrity and correctness of the DHRs. You also plan to train relevant personnel on design, purchasing, quality, production, warehouse, logistics, PMC, and sales department according to the revised procedures and your firm plans to perform a retrospective review for all products which had been sold for the US market. These actions have not been completed; therefore, the adequacy of these actions cannot be determined until the activities described have been completed and documentation verifying the successful completion of these actions are provided.</p>

<p>8. Failure to maintain device master records (DMRs) as required by 21 CFR 820.181.</p>

<p>For example: Your firm has not maintained their Device Master Records related to the subject device, and the personnel was unfamiliar with documents, processes, and medical devices related to the U.S market. Additionally, the manager of the site was not familiar with the FDA regulatory requirements to include DMRs for medical device manufacturers.</p>

<p>We have reviewed your firm’s response in the 483 Corrective Action Plan. The adequacy of the response dated October 8, 2021, cannot be determined at this time. You plan to output DMRs according to the reorganized Device History File for all products exported and intended for the U.S market, and to retrospectively review for all products which have been sold for the US market, to analyze if there are any quality issues or adverse events that have occurred. These actions have not been completed; therefore, the adequacy of these actions cannot be determined until the activities described have been completed and documentation verifying the successful completion of these actions are provided.</p>

<p>Given the serious nature of the violations of the Act, Veress Pneumoperitoneum Needles manufactured by your firm are subject to refusal of admission under section 801(a) of the Act, 21 U.S.C. § 381(a), in that they appear to be adulterated. As a result, FDA is taking steps to refuse entry of these devices into the United States, known as 'detention without physical examination,' until these violations are corrected. In order to remove the devices from detention, your firm should provide a written response to this Warning Letter as described below and correct the violations described in this letter. We will notify you regarding the adequacy of your firm's response(s) and the need to re-inspect your firm's facility to verify that the appropriate corrections and/or corrective actions have been made.</p>

<p>Other federal agencies may take your compliance with the FD&amp;C Act and its implementing regulations into account when considering the award of federal contracts. Additionally, should FDA determine that you have Quality System regulation violations that are reasonably related to premarket approval applications for Class III devices, such devices will not be approved until the violations have been addressed.</p>

<p>Please notify this office in writing, within fifteen business days from the date you receive this letter, of the specific steps your firm has taken to correct the noted violations, as well as an explanation of how your firm plans to prevent these violations, or similar violations, from occurring again. Include documentation of the corrections and/or corrective actions (which must address systemic problems) that your firm has taken. If your firm's planned corrections and/or corrective actions will occur over time, please include a timetable for implementation of those activities. If corrections and/or corrective actions cannot be completed within fifteen business days, state the reason for the delay and the time within which these activities will be completed.</p>

<p>Your firm's response should be comprehensive and address all violations included in this Warning Letter. If you believe that your products are not in violation of the FD&amp;C Act, include your reasoning and any supporting information for our consideration as part of your response. Please provide a translation of documentation not in English to facilitate our review.</p>

<p>Your firm's response should be sent to CDRHWarningLetterResponses@fda.hhs.gov, or if e-mail cannot be used:</p>

<p>Food and Drug Administration - CDRH/ORP/DRP2<br />
CDRH Regulatory Inspections and Audit Team, WO66-1434<br />
10903 New Hampshire Ave.<br />
Silver Spring, MD 20993</p>

<p><strong>Refer to CMS case #424228 when replying</strong>. If you have any questions about the contents of this letter, please contact: OHT Assistant Director, Jason Roberts at jason.roberts@fda.hhs.gov or (240)402-6400</p>

<p>Finally, you should know that this letter is not intended to be an all-inclusive list of the violations at your firm's facility. It is your firm's responsibility to ensure compliance with applicable laws and regulations administered by FDA. The specific violations noted in this letter and in the Inspectional Observations, FDA 483, issued at the close of the inspection may be symptomatic of serious problems in your firm's manufacturing and quality management systems. Your firm should investigate and determine the causes of the violations, and take prompt actions to correct the violations and bring the products into compliance.</p>

<p>Sincerely Yours,<br />
/S/</p>

<p>Courtney H. Lias, Ph.D.<br />
Office Director<br />
OHT3: Office of GastroRenal, ObGyn,<br />
General Hospital and Urology Devices<br />
Office of Product Evaluation and Quality<br />
Center for Devices and Radiological Health</p>

<p>CC:<br />
Zeyu Chen<br />
238 Fernwood Ave, Edison, NEW JERSEY 08837</p>


<!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET-->
<!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET-->



              
                                            
              
            </div>

                                                  
                          <aside class="col-md-2" role="complementary">
                <section id="block-entityviewcontent-4" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

        <div class="region region-">
  <aside class="lcds-card lcds-card--border-top">
    <ul role="menu" class="lcds-description-list">
      
                            


























  <li role="menuitem" class="node-current-date lcds-description-list__item">
    <div>
      <h2 class="lcds-description-list__item-heading">Content current as of:</h2>
      <p class="lcds-description-list__item-text"><time datetime="2022-03-22T09:20:00Z">03/22/2022</time>
</p>
    </div>
  </li>
               
                
<li role="menuitem" class="lcds-description-list__item">  
	<div>
		
		 <h2 class="lcds-description-list__item-heading">Regulated Product(s)</h2>
		 <ul role="menu" class="lcds-metadata-list">
						  <li role="menuitem">Medical Devices</li>
			  			     			  						              
			
			
			
			
			
			
			
			
					</ul>
	 
			     
						       

			  
						  

			  
						 
	</div>
</li>   

    </ul>

  </aside>
</div>


  </section>


              </aside>
            
                 </article>        
      </main>

    </div>  </div>
<div id="fda-survey-comments"></div>
<script src=https://touchpoints.app.cloud.gov/touchpoints/0eb673d9.js async></script>
<button class="btn btn-primary btn-vertical" id="survey-btn">Feedback</button>
<script src=https://touchpoints.app.cloud.gov/touchpoints/d45bb814.js async=""></script>
                <div class="region region-subscribe">
    <section id="block-entityviewcontent-5" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      

  </section>


  </div>

  
      <footer id="footer" class="lcds-footer container-fluid">
        
    <div class="row lcds-footer__primary">
    <nav class="text-center">
      <div class="col-sm-4">
        <ul class="nav">
          <li><a href="/about-fda/about-website/fdagov-archive" >FDA Archive</a></li>
          <li><a href="/about-fda" >About FDA</a></li>
          <li><a href="/about-fda/about-website/internet-accessibility" >Accessibility</a></li>
        </ul>
      </div>
      <div class="col-sm-4">
        <ul class="nav">
          <li><a href="/about-fda/visitor-information" >Visitor Information</a> </li>
          <li><a href="/about-fda/about-website/website-policies" >Website Policies / Privacy</a></li>
          <li><a href="/about-fda/jobs-and-training-fda/no-fear-act" >No FEAR Act</a></li>
          <li><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" >Vulnerability Disclosure Policy</a></li>
        </ul>
      </div>
      <div class="col-sm-4">
        <ul class="nav">
          <li><a href="/regulatory-information/freedom-information" title="Freedom of Information Act">FOIA</a></li>
          <li><a href="https://www.hhs.gov/" title="Health and Human Services" target="_blank">HHS.gov</a></li>
          <li><a href="https://www.usa.gov/" target="_blank">USA.gov</a></li>
        </ul>
      </div>
    </nav>
  </div>
    <div class="row lcds-footer__secondary">
    <div class="col-sm-12 col-md-6 col-lg-4 lcds-footer__social-links">
      <a href="/about-fda/contact-fda" class="btn btn-default btn-md">Contact FDA</a>
      <a href="https://www.facebook.com/FDA" title="Follow FDA on Facebook" class="no-disclaimer"> 
        <span class="fa fa-facebook fa-2x" aria-hidden="true">
          <span class="sr-only">Follow FDA on Facebook</span> 
        </span>
      </a>
      <a href="https://x.com/US_FDA" title="Follow FDA on X" class="no-disclaimer">
        <svg class="icon-svg-inline fa-2x" aria-hidden="true">
          <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter">
        </svg>
        <span class="sr-only">Follow FDA on X</span>
      </a>
      <a href="https://instagram.com/FDA" title="Follow FDA on Instagram" class="no-disclaimer">
        <span class="fa fa-instagram fa-2x" aria-hidden="true"> 
          <span class="sr-only">Follow FDA on Instagram</span>
        </span>
      </a>
      <br class='visible-xs-inline'/>
      <a href="https://www.linkedin.com/company/fda/" title="Follow FDA on LinkedIn" class="no-disclaimer">
        <span class="fa fa-linkedin fa-2x" aria-hidden="true"> 
          <span class="sr-only">Follow FDA on LinkedIn</span>
        </span>
      </a>
      <a href="https://youtube.com/@US_FDA" title="View FDA videos on YouTube" class="no-disclaimer">
        <span class="fa fa-youtube fa-2x" aria-hidden="true"> 
          <span class="sr-only">View FDA videos on YouTube</span>
        </span>
      </a>
      <a href="/about-fda/contact-fda/subscribe-podcasts-and-news-feeds" title="Subscribe to FDA RSS feeds">
        <span class="fa fa-rss fa-2x" aria-hidden="true">
          <span class="sr-only">Subscribe to FDA RSS feeds</span>
        </span>
      </a>
    </div>
    <a href="/" title="FDA Homepage">
        <div class="visible-lg-block col-lg-4 text-center">
          <img src="/themes/custom/preview/assets/images/FDA_Logo_Icon_White.svg" height="60px" alt="Food and Drug Administration Logo">
        </div>
    </a>
    <div class="col-sm-12 col-md-6 col-lg-4 text-center lcds-footer__contact-number">
      <span class="fa fa-phone" aria-hidden="true"> </span> 
     <span class="sr-only">Contact Number</span>
      1-888-INFO-FDA (1-888-463-6332)
    </div>
  </div>
  
      <!--END WEBSITE FEEDBACK SNIPPET-->
  

    </footer>
    <a href="" id="btn-top" class="btn btn-primary btn-top"><span class="sr-only">Back to </span>Top</a>
  

  </div>

    
    <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/413071","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"fda_ckeditor_enhancements":{"basePath":"modules\/custom\/fda_ckeditor_enhancements"},"google_analytics":{"account":"G-273DTKB5QW","trackOutbound":true,"trackMailto":true,"trackTel":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"bootstrap":{"forms_has_error_value_toggle":1,"modal_animation":1,"modal_backdrop":"true","modal_focus_input":1,"modal_keyboard":1,"modal_select_text":1,"modal_show":1,"modal_size":"","popover_enabled":1,"popover_animation":1,"popover_auto_close":1,"popover_container":"body","popover_content":"","popover_delay":"0","popover_html":0,"popover_placement":"right","popover_selector":"","popover_title":"","popover_trigger":"click"},"ajax":[],"user":{"uid":0,"permissionsHash":"1b1b521ce0efd787b9481ef00f514b542eb396217a4d74c357d2ecd6b6b52a2d"}}</script>
<script src="/files/js/js_6wBZHfpF3KVtBs6ZtLrAw5oAvps3vbyTaoe7yxCXDtU.js?scope=footer&amp;delta=0&amp;language=en&amp;theme=preview&amp;include=eJxdjtEKwjAMRX9oo74I_k3J0hiLXROSMJlfL1Ms4uM9JOdeFuFGGTq0PSp64j8wqdFW6ZG4yQJtdrSq4dMiEh4GmlRUNrLpWiDjnUoNsUz9Bh1ppR6eAFGsVOk5hA-738QCpdDnSVZt9ThPR5Pn8-nyA8cCNHjuxDxAAX1Lvnlo59H4Ai47WJ8"></script>

  </body>
</html>
